PAO Group, Inc. (PAOG)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 5, 2025, 8:00 PM EDT
PAO Group Market Cap
PAO Group has a market cap or net worth of $1.91 thousand as of August 7, 2025. Its market cap has decreased by -99.89% in one year.
Market Cap
1.91K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 16, 2019, PAO Group's market cap has decreased from 2.21M to 1.91K, a decrease of -99.91%. That is a compound annual growth rate of -69.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 1.91K | -99.67% |
| Dec 31, 2024 | 573.06K | -40.00% |
| Dec 29, 2023 | 955.09K | 25.00% |
| Dec 30, 2022 | 764.07K | -84.62% |
| Dec 31, 2021 | 4.97M | 76.34% |
| Dec 31, 2020 | 2.82M | 695.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.57M |
| Glass House Brands | 474.59M |
| Spruce Biosciences | 427.59M |
| Northwest Biotherapeutics | 368.08M |
| CytoDyn | 337.23M |